| Product Name | MF | CAS | Details |
|---|
| RSS0680 | C52H64N10O6S3 | 2769753-48-0 | Details |
| Brentuximab | 2088770-90-3 | Details |
| Moiramide B | C25H31N3O5 | 155233-31-1 | Details |
| AC 7739 | C18H21NO4.ClH | 162705-22-8 | Details |
| MitoSOX Red | C43H43IN3P | 1003197-00-9 | Details |
| Myosin V-IN-1 | C29H26N6O3S | 1259177-59-7 | Details |
| lorvotuzumab | 339306-30-8 | Details |
| PARP-2-IN-3 | C20H20ClN3O3 | 2915650-86-9 | Details |
| TV 3279 | C16H20N2O2 | 209394-29-6 | Details |
| (Rac)-SHIN2 | C23H26N4O3 | 2204289-53-0 | Details |
| Senktide acetate | Details |
| GSK3-IN-3 | C24H35N3O4 | 331963-27-0 | Details |
| Simmitecan hydrochloride | C34H39ClN4O6 | 1247847-78-4 | Details |
| Pincainide | C16H24N2O | 83471-41-4 | Details |
| PCSK9-IN-10 | C18H23N5O4 | 368434-98-4 | Details |
| PLH1215 | 1332084-64-6 | Details |
| Xanthine oxidoreductase-IN-5 | C17H17N5O2 | 1026652-90-3 | Details |
| Clivatuzumab | 1622075-09-5 | Details |
| Turosteride | C27H45N3O3 | 137099-09-3 | Details |
| ccc_R08 | C22H19ClO6 | 2919019-72-8 | Details |
| SMN-C2 | C24H27N5O2 | 1446311-56-3 | Details |
| USP28-IN-3 | C23H20Cl2N2O3S | 2931509-14-5 | Details |
| Binospirone | C20H26N2O4 | 102908-59-8 | Details |
| DATPT | C24H38N6O3.ClH | 2891582-75-3 | Details |
| Sonepcizumab | 1031360-18-5 | Details |
| p53 Activator 7 | C27H32F3N4OP | 2849340-59-4 | Details |
| DC-BPi-03 | C14H14N4O2S | 2758411-46-8 | Details |
| Larotinib | C24H26ClFN4O4 | 1438072-11-7 | Details |
| CIA-1 (Free base) | C17H19N3O2S | 452087-38-6 | Details |
| HDAC-IN-57 | C21H19N3O4 | 2716217-79-5 | Details |
| GSNKGAIIGLM(131602-53-4(free base)) | C45H81N13O14S | Details |
| OTUB1/USP8-IN-1 | C22H16ClFN2O4 | 2858800-98-1 | Details |
| Plogosertib | C34H48N8O3 | 1137212-79-3 | Details |
| PF-17 | C21H28N4O5S | 2697145-21-2 | Details |
| SOS1-IN-15 | C28H27F3N6O2 | 2793404-47-2 | Details |
| M3541 | C23H17FN6O2 | 1360628-91-6 | Details |
| ZIM | C20H19N3O3 | 301298-87-3 | Details |
| Enfortumab | 1448664-46-7 | Details |
| PLH2058 | 2525206-41-9 | Details |
| Navamepent | C18H24O4 | 1251537-11-7 | Details |
| Zilovertamab | 1643432-38-5 | Details |
| TJ08 | C22H16FN3O4 | 2924274-19-9 | Details |
| TGFβ1-IN-3 | C23H30N4O5 | 2883813-58-7 | Details |
| PARP1/2/TNKS1/2-IN-1 | C35H31FN6O5 | 2243453-32-7 | Details |
| Bivatuzumab | 214559-60-1 | Details |
| NP10679 | C23H26F3N3O3 | 2914889-88-4 | Details |
| BMS-823778 | C18H18ClN3O | 1140897-32-0 | Details |
| Ebaresdax hydrochloride | C12H15ClN2O3S | 1334385-87-3 | Details |
| Glembatumumab vedotin | 1182215-65-1 | Details |
| P 218 | C18H25ClN4O4 | 1142407-60-0 | Details |
| Akt3 degrader 1 | C53H72N8O4 | 2836342-69-7 | Details |
| Nampt activator-2 | C17H15ClN4O3S | 2237268-90-3 | Details |
| APOBEC3G-IN-1 | C15H11NO3 | 14261-92-8 | Details |
| hCAII-IN-9 | C15H16ClN3O5S2 | 2878477-18-8 | Details |
| Theralizumab | 906068-56-2 | Details |
| TNF-α-IN-9 | C17H14O4 | 2054199-25-4 | Details |
| SF-22 | C28H26N2O3S | 824981-55-7 | Details |
| [Sar1, Ile8]-Angiotensin II 3TFA | C46H73N13O10 | Details |
| [Leu5]-Enkephalin acetate(58822-25-6 free base) | C28H37N5O7 | Details |
| SID-852843 | C17H15N3O5S | 909859-19-4 | Details |
| (R)-HH2853 | C31H36F3N7O3 | 2202678-06-4 | Details |
| 11β-HSD1 inibitor 19 | C19H16ClF4N3O2S | 946400-19-7 | Details |
| AXL-IN-13 | C34H41FN6O5 | 2376928-82-2 | Details |
| MyD88-IN-1 | C23H24N6O7S | 2911609-80-6 | Details |
| AUTAC1 | C44H63FN8O11S | 2241669-09-8 | Details |
| GW297361 | C16H12N4O3S2 | 388627-21-2 | Details |
| (R)-BI-2852 | C31 H28 N6 O2 | 2375482-49-6 | Details |
| ENT-C225 | C26H40N4O5 | 2919962-53-9 | Details |
| NSC243928 mesylate | C22H21N3O3S.CH4O3S | 59988-01-1 | Details |
| RSH-7 | C22H25FN8O | 2764609-97-2 | Details |
| Xanthine oxidoreductase-IN-3 | C14H10ClN5O | 651769-78-7 | Details |
| PRMT6-IN-3 | C19H26N4O2S | 2890765-10-1 | Details |
| CYP4A11/CYP4F2-IN-1 | C15H15N3OS | 502654-40-2 | Details |
| PU.1-IN-1 | C18H22N2O2S | 873588-27-3 | Details |
| BPDA2 | C24H30O5 | 2907659-86-1 | Details |
| CZL55 | C20H22N2O6 | 667408-87-9 | Details |
| Cibisatamab | 1855925-27-7 | Details |
| CpG ODN 10101 | 1234402-77-7 | Details |
| STING agonist-30 | C15H16N4O8 | 2951078-67-2 | Details |
| SFI003 | C19H17N5OS | 2361332-90-1 | Details |
| (S)-VU0637120 | C16H19N3O5S2 | 1175940-86-9 | Details |
| Dazostinag disodium | C21H23F2N8NaO10P2S2 | 2553413-93-5 | Details |
| Angiotensin 1/2 (1-9) TFA | Details |
| STC314 | C13H25NaO32S7 | 186295-19-2 | Details |
| Atibeprone | C17H18N2O3S | 153420-96-3 | Details |
| Endo-1,3-β-glucanase | 9025-37-0 | Details |
| PDCD4-IN-1 | C12H9BrClN3O | 494763-64-3 | Details |
| Inotuzumab | 1660159-36-3 | Details |
| Ordesekimab | 879293-15-9 | Details |
| TGFβ1-IN-2 | C23H30N4O4S | 2700263-58-5 | Details |
| DPTN dihydrochloride | C22H18N4OS.2ClH | 325767-87-1 | Details |
| CYP1B1-IN-5 | C14H8INO2 | 176442-56-1 | Details |
| Nemazoline Free Base | C10H11Cl2N3 | 130759-56-7 | Details |
| pCDPK1/TgCDPK1-IN-3 | C17H18N6 | 1092788-87-8 | Details |
| R 59-022 hydrochloride | C27H27ClFN3OS | 93076-98-3 | Details |
| GRGDSPK acetate | 144027-77-0 | Details |
| SRI-42127 | C19H20N6O | 2727872-68-4 | Details |
| CLK8 | C29H26N2O6 | 898920-65-5 | Details |
| JNJ-49095397 | C34H36N6O4 | 1220626-82-3 | Details |
| DSPE-NHS | C49H89N2O13P | 1383932-86-2 | Details |
| Product Total： Product Page： | ||||
| 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 | ||||